Alkem Laboratories Ltd.

BSE: 539523 | NSE: ALKEM |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category

Series: EQ | ISIN: INE540L01014 | SECTOR: Pharmaceuticals & DrugsPharmaceuticals & Drugs

Success

Alert

Please select a Day.

Info

Open trading A/c Open trading A/c

Alkem Laborato Alkem Laboratories Ltd. | BSE 5692.95 58.15 (1.03%) | NSE 5696.50 54.50 (0.97%) | Trade | Add

BSE Live

Apr 21, 16:01

5692.95 58.15 (1.03%)

Volume

AVERAGE VOLUME

5-Day

2,542

10-Day

7,067

30-Day

12,167

2,448

Prev. Close

5634.80
Open Price

5655.05

Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)

NSE Live

Apr 21, 15:47

5696.50 54.50 (0.97%)

Volume

AVERAGE VOLUME

5-Day

132,612

10-Day

123,544

30-Day

118,456

127,553

Prev. Close

5642.00
Open Price

5664.00

Bid Price (Qty.)
5696.50 (50)
Offer Price (Qty.)
0.00 (0)

Financials

Print/Copy to Excel : Go

Profit & Loss account of Alkem Laboratories (in Rs. Cr.)	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21
	12 mths	12 mths	12 mths	12 mths	12 mths
INCOME
Revenue From Operations [Gross]	12,804.62	12,439.24	11,440.35	10,634.19	8,728.40
Less: Excise/Sevice Tax/Other Levies	0.00	0.00	0.00	0.00	0.00
Revenue From Operations [Net]	12,804.62	12,439.24	11,440.35	10,634.19	8,728.40
Total Operating Revenues	12,964.52	12,667.58	11,599.26	10,634.19	8,865.01
Other Income	493.74	310.84	216.08	162.65	233.21
Total Revenue	13,458.26	12,978.42	11,815.34	10,796.84	9,098.22
EXPENSES
Cost Of Materials Consumed	3,440.37	3,294.59	3,056.92	3,226.06	2,394.54
Purchase Of Stock-In Trade	1,514.02	1,628.87	1,387.55	1,489.71	1,437.76
Operating And Direct Expenses	0.00	0.00	0.00	0.00	0.00
Changes In Inventories Of FGWIP And Stock In Trade	-190.13	14.12	462.37	-535.48	-333.84
Employee Benefit Expenses	2,453.92	2,201.01	2,131.35	1,962.71	1,621.03
Finance Costs	121.70	112.41	107.36	52.37	58.92
Depreciation And Amortisation Expenses	357.16	299.30	310.42	303.96	274.58
Other Expenses	3,234.19	3,283.50	2,951.62	2,438.27	1,803.13
Total Expenses	10,931.23	10,833.80	10,407.59	8,937.60	7,256.12
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax	2,527.03	2,144.62	1,407.75	1,859.24	1,842.10
Exceptional Items	0.00	-121.49	-102.98	-14.96	0.00
Profit/Loss Before Tax	2,527.03	2,023.13	1,304.77	1,844.28	1,842.10
Tax Expenses-Continued Operations
Current Tax	523.60	422.28	273.90	361.98	396.53
Less: MAT Credit Entitlement	0.00	0.00	0.00	0.00	0.00
Deferred Tax	-212.57	-210.61	24.06	-198.02	-172.20
Other Direct Taxes	0.00	0.00	0.00	0.00	0.00
Total Tax Expenses	311.03	211.67	297.96	163.96	224.33
Profit/Loss After Tax And Before ExtraOrdinary Items	2,216.00	1,811.46	1,006.81	1,680.32	1,617.77
Profit/Loss From Continuing Operations	2,216.00	1,811.46	1,006.81	1,680.32	1,617.77
Profit/Loss For The Period	2,216.00	1,811.46	1,006.81	1,680.32	1,617.77
Minority Interest	-49.90	-15.69	-22.64	-34.70	-32.75
Consolidated Profit/Loss After MI And Associates	2,165.48	1,795.77	984.17	1,645.62	1,585.02
OTHER ADDITIONAL INFORMATION
EARNINGS PER SHARE
Basic EPS (Rs.)	181.00	150.00	82.00	138.00	133.00
Diluted EPS (Rs.)	181.00	150.00	82.00	138.00	133.00
DIVIDEND AND DIVIDEND PERCENTAGE
Equity Share Dividend	502.17	538.04	526.09	0.00	334.78
Tax On Dividend	0.00	0.00	0.00	0.00	0.00